Top Companies - Osteoporosis Treatment Industry

Genetic factors, inadequate calcium, magnesium, and vitamin D intake, eating disorders like anorexia, inactivity and immobility, and excessive alcohol consumption are just a few of the causes of osteoporosis. Cancer, chronic kidney disease, chronic obstructive pulmonary disease, and some autoimmune diseases like rheumatoid arthritis are additional conditions that raise the risk of osteoporosis.

The market for Treating Osteoporosis worldwide is anticipated to reach US$ 14.01 billion in 2022 and grow at a CAGR of 3.8% during the forecast period (2022-2030).

Leading Companies in the Osteoporosis Treatment Industry:

Teva Pharmaceutical Industries Ltd.

Israeli multinational pharmaceutical company Teva Pharmaceutical Industries Ltd. is based in Tel Aviv. Generic drugs are its main area of expertise, but it also has some other business interests in active pharmaceutical ingredients and, to a lesser extent, proprietary drugs.

Teva declares the exclusive release of generic Actonel tablets in the US

DAIICHI SANKYO COMPANY, LIMITED

The second-largest pharmaceutical company in Japan is Daiichi Sankyo Company, Limited, a multinational corporation. In 2019, it generated JPY 981.8 billion in revenue.

PRALIA Subcutaneous Injection 60mg Syringe, a New Osteoporosis Treatment, is Introduced by Daiichi Sankyo

Amgen Inc.

A multinational biopharmaceutical company with its main office in Thousand Oaks, California, is called Amgen Inc. Amgen, one of the biggest independent biotechnology firms in the world, was founded in 1980 in Thousand Oaks, California.

The treatment of osteoporosis in postmenopausal women who are at high risk of fracture with EVENIT has received FDA approval.

Dr. Reddy’s Laboratories Ltd.

Hyderabad-based Dr. Reddy's Laboratories is a multinational pharmaceutical corporation in India. Kallam Anji Reddy, who had previously worked for the mentor company Indian Drugs and Pharmaceuticals Limited, founded the business.

Osteoporosis medication was released on the market by Dr. Reddy's Laboratories.

Viatris Inc.

The corporate headquarters of the American pharmaceutical and healthcare giant Viatris Inc. are in Canonsburg, Pennsylvania. On November 16, 2020, Mylan and Upjohn, a former Pfizer division, merged to create the company.

Teriparatide from Strides and pirfenidone from Viatris are approved by CHMP.

Ligand Pharmaceuticals Incorporated

San Diego, California-based Ligand Pharmaceuticals is a biopharmaceutical business. Progenix Inc. was established in 1987, and the business went public in 1992.

Ligand and Chiva Pharmaceuticals Sign a Global Licensing Agreement for Fablyn (R)

Eli Lilly and Company

With offices across 18 nations, Eli Lilly and Company is an American pharmaceutical company with its main office in Indianapolis, Indiana. Approximately 125 countries sell its products. The business was established in 1876 and is named after Colonel Eli Lilly, a pharmacist and American Civil War veteran.

The European Committee for Medicinal Products for Human Use for the Treatment of Glucocorticoid-Induced Osteoporosis has given FORSTEO(R) a favourable opinion.

Asahi Kasei Corporation

The multinational Japanese chemical company Asahi Kasei Corporation. Chemicals and materials science are two of its primary outputs. It was established in May 1931 using the paid-in capital of Nobeoka Ammonia Fiber Co., Ltd, a manufacturer of ammonia, nitric acid, and other chemicals with its headquarters in Nobeoka, Miyazaki.

Reclast for i.v. infusion bag product marketing and listing on the NHI drug price standard announcement.

*Definition:

Osteoporosis makes bones weak and brittle, so brittle that even minor stresses like coughing or bending over can break them.